Skip to main content
NIH funding notice PA-19-043

Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed)

Closed on September 5, 2021.

Posted
October 31, 2018
Close date
September 5, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $596,943 in first-year total cost, median $298,472.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IMST-H (15)]2

Most frequent institutions

  1. NEMAMETRIX, INC.1
  2. OCTANT, INC.1
Competing awards under PA-19-043 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Functional Assessment of Variants in Organisms of Research (FAVOR) - Profiling Canonical Human Genes and their Variants through Disease Model Phenotyping.1R43HG010852-01A1BROCK, TRISHAHOPKINS, CHRISTOPHER EMCCORMICK, KATHRYN ENEMAMETRIX, INC., OR$350,000ZRG1
2020Functional Genomics of G Protein-Coupled Receptors1R43GM137745-01KOSURI, SRIRAMOCTANT, INC., CA$246,943ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-19-043: Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed) | ScienceDex | ConductScience